P. Goeminne (Bornem, Belgium), M. Shteinberg (Haifa, Israel)
This session is built from abstracts published on the ERS Congress platform from 23 August, in a PowerPoint format with a pre-recorded audio narration. The live session is scheduled from September 5-7 and each presenter will have a 5-minutes live, slide show presentation followed at the end of the session by 30-minutes general discussion.
The bronchiectasis ‘bacteriophagome’
M. Mac Aogáin (Singapore, Singapore), F. Ivan (Singapore, Singapore), T. Jaggi (Singapore, Singapore), H. Keir ( Dundee, Scotland, United Kingdom), A. Dicker ( Dundee, Scotland, United Kingdom), A. Hou (Singapore, Singapore), M. Poh ( Kuala Lumpur, Malaysia), M. Oriano ( Milan, Italy), M. Koh (Singapore, Singapore), O. How (Singapore, Singapore), A. Tee (Singapore, Singapore), T. Low (Singapore, Singapore), J. Abisheganaden (Singapore, Singapore), S. Aliberti ( Milan, Italy), F. Blasi ( Milan, Italy), J. Chalmers ( Dundee, Scotland, United Kingdom), S. Chotirmall (Singapore, Singapore)
|    |
Characterisation of eosinophilic bronchiectasis: A European multicohort study
A. Shoemark (Dundee, United Kingdom), M. Shteinberg (Haifa, Israel), A. De Soyza (Newcastle, United Kingdom), C. Haworth (Cambridge, United Kingdom), H. Richardson (Dundee, United Kingdom), L. Perea (Barcelona, Spain), A. Dicker ( Dundee, United Kingdom), P. Goeminne (Leuven, Belgium), E. Cant (Dundee, United Kingdom), E. Polverino (Barcelona, Spain), J. Altenburg (Amsterdam, Netherlands), H. Keir (Dundee, United Kingdom), M. Loebinger (London, United Kingdom), F. Blasi (Milan, Italy), T. Welte (Hannover, Germany), O. Sibila (Barcelona, Spain), S. Aliberti (Milan, Italy), J. Chalmers (Dundee, United Kingdom)
| |
The microbiology of stable bronchiectasis: data from the EMBARC bronchiectasis registry
M. Shteinberg (Haifa, Israel), E. Polverino (Barcelona, Spain), P. Burgel (Paris, France), C. Haworth (Cambridge, United Kingdom), K. Dimakou (Athens, Greece), A. Hill (Edinburgh, United Kingdom), M. Loebinger (London, United Kingdom), R. Menendez (Valenica, Spain), A. Torres (Barcelona, Spain), T. Welte (Hannover, Germany), F. Blasi (Milan, Italy), F. Ringshausen (Hannover, Germany), A. De-Soyza (Newcastle, United Kingdom), M. Vendrell (Girona, Spain), A. Shoemark (Dundee, United Kingdom), W. Boersma (Alkmaar, Netherlands), R. Wilson (London, United Kingdom), J. Chalmers (Dundee, United Kingdom), S. Elborn (Belfast, United Kingdom), S. Aliberti (Milan, Italy), P. Goeminne (Sint-Niklaas, Belgium), J. Altenburg (Amsterdam, Netherlands)
| |
Changes in sputum bacterial density in people with bronchiectasis: BRONCH UK Study data
Z. Alfahl (Belfast , United Kingdom), G. Einarsson (Belfast, United Kingdom), K. O’Neill (Belfast, United Kingdom), D. F. Gilpin (Belfast, United Kingdom), J. Elborn (Belfast, United Kingdom), K. Ferguson (Belfast, United Kingdom), A. Hill (Edinburgh, United Kingdom), M. Loebinger (London , United Kingdom), M. Carroll (Southampton, United Kingdom), T. Gatheral (Lancaster, United Kingdom), A. De Soyza (Newcastle, United Kingdom), J. Chalmers (Dundee , United Kingdom), C. Johnson (Cambridge , United Kingdom), J. Hurst (London, United Kingdom), J. Brown (London, United Kingdom), J. M. Bradley (Belfast, United Kingdom), M. M. Tunney (Belfast, United Kingdom)
| |
Sputum neutrophil elastase and inhaled antibiotic response in bronchiectasis: a post-hoc analysis of the ORBIT-4 trial
H. Abo-Leyah (Dundee, United Kingdom), H. Richardson (Dundee, United Kingdom), T. Pembridge (Dundee, United Kingdom), Y. Gao (Dundee, United Kingdom), P. Goeminne (Sint-Niklaas, Belgium), C. Haworth (Cambridge, United Kingdom), J. Chalmers (Dundee, United Kingdom)
| |
Mapping inflammatory endotypes of bronchiectasis associated with impaired mucociliary clearance
M. Bottier (Dundee, United Kingdom), E. Cant (Dundee, United Kingdom), L. Delgado (Dundee, United Kingdom), D. Cassidy (Dundee, United Kingdom), Y. Giam (Dundee, United Kingdom), A. Smith (Dundee, United Kingdom), H. Richardson (Dundee, United Kingdom), A. Dicker (Dundee, United Kingdom), J. Huang (Dundee, United Kingdom), H. Keir (Dundee, United Kingdom), L. Perea (Barcelona, Spain), S. Finch (Dundee, United Kingdom), S. Aliberti (Monza, Italy), O. Sibila (Barcelona, Spain), J. Chalmers (Dundee, United Kingdom), A. Shoemark (Dundee, United Kingdom)
| |
Inhaled corticosteroids use in patients with bronchiectasis: Data from the EMBARC registry
E. Polverino (Barcelona, Spain), J. Chalmers (Dundee, United Kingdom), S. Aliberti (Milan, Italy), C. Haworth (Cambridge, United Kingdom), F. Blasi (Milan, Italy), W. Boersma (Alkmaar, Netherlands), A. De Soyza (Newcastle, United Kingdom), K. Dimakou (Athens, Greece), S. Elborn (Belfast, United Kingdom), M. Loebinger (London, United Kingdom), A. Torres (Barcelona, Spain), M. Shteinberg (Haifa, Israel), T. Welte (Hannover, Germany), M. Vendrell (Girona, Spain), F. Ringshausen (Hannover, Germany), R. Menendez (Valencia, Spain), A. Shoemark (Dundee, United Kingdom), P. Burgel (Paris, France), P. Goeminne (Nikolaas, Belgium)
| |
Salivary proinflammatory cytokines and airway bacterial infection in Bronchiectasis
L. Perea Soriano (Barcelona (CT), Spain), R. Faner (Barcelona (CT), Spain), B. Solarat (Barcelona (CT), Spain), A. Agustí (Barcelona (CT), Spain), O. Sibila (Barcelona (CT), Spain)
| |
Immunometabolic markers and the sputum microbiome in bronchiectasis
Y. Giam (Dundee, United Kingdom), H. Richardson (Dundee, United Kingdom), A. Smith (Cambridge, United Kingdom), H. Keir (Dundee, United Kingdom), D. Cassidy (Dundee, United Kingdom), S. Finch (Dundee, United Kingdom), S. Aliberti (Milan, Italy), O. Sibila (Barcelona, Spain), A. Shoemark (Dundee, United Kingdom), J. Chalmers (Dundee, United Kingdom)
| |
Late Breaking Abstract - The respiratory tract of patients with antibody deficiency on immunoglobulin replacement is characterised by inflammation and dysbiosis despite adequate levels of sputum IgG
A. Schnell (Bern, Switzerland), D. Lowe (London, United Kingdom), S. Graeter (Bern, Switzerland), M. Davrandi (London, United Kingdom), S. Burns (London, United Kingdom), A. Schaub (Bern, Switzerland), M. Saxenhofer (Bern, Switzerland), M. Hauswald (Marburg, Germany), C. Witte (Marburg, Germany), C. Leboreiro (London, United Kingdom), F. Moreira (London, United Kingdom), I. Irincheeva (Bern, Switzerland), I. Schulze (Bern, Switzerland), C. Vonarburg (Bern, Switzerland), A. Feussner (Marburg, Germany)
| |
Discussion
| |